Grants and Contributions:
Title:
Enhanced European Market Penetration of Neurodegenerative Disease Research Tools
Agreement Number:
947693
Agreement Value:
$21,000.00
Agreement Date:
Apr 1, 2020 - Sep 30, 2020
Description:
Stressmarq Biosciences Inc. Has developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research. The company aims to increase it's export of these to five key European territories.
Organization:
National Research Council Canada
Expected Results:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Victoria, British Columbia, CA V8T 2C1
Reference Number:
172-2020-2021-Q1-947693
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
838513760
Recipient Type:
For-profit organization
Recipient's Legal Name:
Stressmarq Biosciences Inc.
Federal Riding Name:
Victoria
Federal Riding Number:
59041
Program:
CanExport SMEs
Program Purpose:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541710